Company
LXEO · CIK 0001907108
Acquisition (code A) of 2,306 shares at $2.644 per share.
Reporting Person Townsend Richard Nolan · Officer Title Chief Executive Officer · Transaction Code A
Traded Sep 14, 2026 · Disclosed Sep 28, 2026FILED +14 DAYS
Source: SEC Form 4 · 0001995218-26-000017 · filed 2026-09-28 · View filing →
Acquisition (code A) of 2,110 shares at $2.644 per share.
Reporting Person Otero Jose Manuel · Officer Title Chief Operating Officer · Transaction Code A
Traded Sep 14, 2026 · Disclosed Sep 28, 2026FILED +14 DAYS
Source: SEC Form 4 · 0002024096-26-000015 · filed 2026-09-28 · View filing →
Acquisition (code A) of 2,714 shares at $3.579 per share.
Reporting Person Bhalla Narinder Pal · Officer Title Chief Medical Officer · Transaction Code A
Traded Sep 14, 2026 · Disclosed Sep 28, 2026FILED +14 DAYS
Source: SEC Form 4 · 0002109299-26-000009 · filed 2026-09-28 · View filing →
Sale of 3,345 shares at $4.9512 per share.
Reporting Person Townsend Richard Nolan · Officer Title Chief Executive Officer · Transaction Code S
Traded Aug 18, 2026 · Disclosed Aug 19, 2026
Source: SEC Form 4 · 0001995218-26-000015 · filed 2026-08-19 · View filing →
Sale of 1,304 shares at $4.9571 per share.
Reporting Person Otero Jose Manuel · Officer Title Chief Operating Officer · Transaction Code S
Traded Aug 18, 2026 · Disclosed Aug 19, 2026
Source: SEC Form 4 · 0002024096-26-000013 · filed 2026-08-19 · View filing →
Sale of 4,117 shares at $4.9071 per share.
Reporting Person Tamayo Louis Edward · Officer Title Chief Financial Officer · Transaction Code S
Traded Aug 18, 2026 · Disclosed Aug 19, 2026
Source: SEC Form 4 · 0002083206-26-000007 · filed 2026-08-19 · View filing →